CrowdStrike Holdings, Inc. <CRWD.O>: Oppenheimer raises target price to $250 from $187.5
CRWD•Related News
Phio Pharmaceuticals submits FDA briefing package for PH-762 Phase 2b plan in skin cancer
PHIO•
EastGroup Properties, Inc. <EGP.N>: BMO Cuts Target Price to $225 From $240
EGP•
UGI Corporation: Huntington Securities initiates coverage with outperform rating; target price $54
UGI•
Hub Group forecasts full-year 2026 operating revenue of $3.6 billion-$3.8 billion
HUBG•
Hub Group names Patrick O'Donnell CFO-elect after 2025 10-K filing
HUBG•